| View |
|
DR-XY27243
|
Nitrofurazone
|
None
|
2mg/ g (0.2%)
|
Ointment
|
Antibacterial
|
J. CHEMIE LABORATORIES, INC
|
Philippines
|
Automatic Renewal
|
07 March 2022
|
18 January 2027
|
| View |
|
DR-XY27256
|
Candesartan Cilexetil + Hydrochlorothiazide
|
Blopress Plus
|
16mg/ 12.5mg
|
Tablet
|
Antihypertensive (Angiotensin II Antagonist & Diuretic)
|
Takeda Italis S.p.A.
|
Italy
|
Automatic Renewal
|
05 October 2021
|
11 August 2026
|
| View |
|
DR-XY27262
|
Multivitamins
|
Afforvit
|
[see reverse for formulation]
|
Capsule
|
Vitamins
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
21 January 2022
|
30 January 2027
|
| View |
|
DR-XY27275
|
Salbutamol (as Sulfate)
|
Sedalin
|
1mg/ mL(0.1%)
|
Sterile Solution for Nebulization
|
Bronchodilators
|
El Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
28 February 2022
|
17 July 2027
|
| View |
DR-XY27280_PI_01.pdf
|
DR-XY27280
|
Bisoprolol Fumarate + Hydrochlorothiazide
|
Ziac
|
10mg/ 6.25mg
|
Film-Coated Tablet
|
Beta-adrenoceptor Blocker/ Diuretic
|
Merck KgaA
|
Germany
|
Automatic Renewal
|
27 September 2021
|
06 February 2027
|
| View |
DR-XY27281_PI_01.pdf
|
DR-XY27281
|
Bisoprolol Fumarate + Hydrochlorothiazide
|
Ziac
|
5mg/ 6.25mg
|
Film-Coated Tablet
|
Beta-adrenoceptor Blocker/ Diuretic
|
Merck KgaA
|
Germany
|
Automatic Renewal
|
20 September 2021
|
06 February 2027
|
| View |
|
DR-XY27283
|
Ceftriaxone (As Sodium)
|
Roxon
|
250 mg
|
Powder For Injection (IM/IV)
|
Antibacterials (Cephalosporins)
|
Karnataka Antibiotics & Pharmaceuticals Limited
|
India
|
Automatic Renewal
|
04 February 2022
|
07 February 2027
|
| View |
|
DR-XY27286
|
CEFTRIAXONE SODIUM
|
Roxon
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporins)
|
Karnataka Antibiotics & Pharmaceuticals Limited
|
India
|
Automatic Renewal
|
04 February 2022
|
08 February 2027
|
| View |
|
DR-XY27287
|
Guaifenesin + Salbutamol
|
Ventar EXP
|
50mg/ 1mg per 5mL
|
Syrup
|
Expectorant/Selective Beta-2 Adrenoreceptor Agonist
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
28 December 2021
|
08 February 2027
|
| View |
|
DR-XY27288
|
Guaifenesin + Salbutamol
|
Efamed Plus
|
50mg/ 1mg per 5mL
|
Syrup
|
Expectorant/Selective beta-2-adrenoreceptor
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
28 December 2021
|
08 February 2027
|
| View |
DR-XY27296_PI_01.pdf
|
DR-XY27296
|
Budesonide/ Formoterol Fumarate Dihydrate
|
Symbicort Turbuhaler® 160 Mcg/4.5 Mcg Per Dose Powder For Inhalation
|
160mcg/ 4.5mcg per dose
|
Powder For Inhalation
|
Anti-asthma
|
AstraZeneca AB
|
Sweden
|
Automatic Renewal
|
26 March 2022
|
06 July 2027
|
| View |
DR-XY27297_PI_01.pdf
|
DR-XY27297
|
Budesonide + Formoterol fumarate dihydrate
|
Symbicort
|
80 mcg/ 4.5 mcg per dose
|
Powder for Inhalation
|
Adrenergics and other drugs for obstructive airway disease
|
AstraZeneca AB
|
Sweden
|
-
|
23 May 2022
|
27 September 2027
|
| View |
|
DR-XY27310
|
Dorzolamide (As Hydrochloride) + Timolol (As Maleate)
|
Cosopt
|
20mg / 5mg per mL
|
Sterile Ophthalmic Solution
|
-
|
Fareva Mirabel
|
France
|
Automatic Renewal
|
23 June 2021
|
14 August 2026
|
| View |
DR-XY27346_PIL_01.pdf
|
DR-XY27346
|
Ambroxol Hydrochloride
|
None
|
30 mg/5 mL
|
Forte Syrup
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
18 September 2020
|
25 August 2025
|
| View |
|
DR-XY27347
|
Ambroxol Hydrochloride
|
None
|
15 mg/5 mL
|
Pediatric Syrup
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
18 September 2020
|
20 August 2025
|
| View |
DR-XY27357_PI_01.pdf
|
DR-XY27357
|
Trimetazidine
|
Vastarel MR
|
35mg
|
Modified-Release Tablet
|
-
|
Les Laboratoires Servier Industrie
|
France
|
-
|
28 January 2022
|
15 March 2027
|
| View |
|
DR-XY27363
|
Cefotaxime (As Sodium)
|
None
|
250 mg
|
Powder For Injection
|
Cephalosporins (Third Generation)
|
Karnataka Antibiotics & Pharma Ltd.
|
India
|
Automatic Renewal
|
18 February 2022
|
15 March 2027
|
| View |
|
DR-XY27364
|
Cefotaxime (As Sodium)
|
None
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporins)
|
Karnataka Antibiotics & Pharmaceuticals Limited
|
India
|
Automatic Renewal
|
18 February 2022
|
15 March 2027
|
| View |
DR-XY27388_PI_01.pdf
|
DR-XY27388
|
TRAVOPROST
|
TRAVATAN
|
40mcg/ mL (0.004% w/v)
|
Sterile Ophthalmic Solution
|
-
|
S.A. Alcon-Couvreur N.V.
|
Belgium
|
Automatic Renewal (Variation) re-issuance
|
02 August 2022
|
23 November 2026
|
| View |
|
DR-XY27391
|
Multivitamins + Minerals
Ferrous Sulfate (Equiv To 65 Mg Elemental Iron) 200Mg
Thiamine Hydrochloride (Vit B1) 2 Mg
Riboflavin (Vit B2) 2 Mg
Pyridoxine Hydrochloride (Vit B6) 2 Mg
Ascorbic Acid (Vit. C) 100 Mg
Cyanocobalamin (Vit B12) 10 Mcg
Nicotinamide 20 Mg
Folic Acid 400 Mcg
|
Micron-C
|
200mg/ 2mg/ 2mg/ 2mg/ 10mcg/ 100mg/ 20mg/ 400mcg
|
Capsule
|
Vitamins/ Mineral
|
Drugmaker's Laboratories Inc.
|
Philippines
|
Automatic Renewal
|
28 March 2022
|
25 March 2027
|